We have observed
15 EP applications
Rhiannon Elizabeth Wescott
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after January 23, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
ENHANCED PROTEIN EXPRESSION
STRATEGY FOR SUCROSE REDUCTION AND GENERATION OF INSOLUBLE FIBER IN JUICES
IMMUNOGLOBULIN FUSION PROTEINS
EXTRACELLULAR MATRIX COMPOSITIONS
COMPOSITIONS AND METHODS COMPRISING LG12-CLADE PROTEASE VARIANTS
MEDICAL USES AND METHODS FOR TREATING CANCER USING MONOPOLAR SPINDLE 1 (MPS1) KINASE INHIBITORS
ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS
YEAST HOST CELLS EPXRESSING A GLUCOAMYLASE FROM ASPERGILLUS FUMIGATUS AND METHODS OF USE THEREOF
FUNGAL CELLS THAT PRODUCE DECREASED AMOUNTS OF PEPTAIBOLS
TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY USING PLACENTAL CELLS
CELL POTENCY ASSAY
NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF
INHIBITORS OF ATAXIA-TELANGIECTASIA MUTATED AND RAD3-RELATED PROTEIN KINASE (ATR) FOR USE IN METHODS OF TREATING CANCER